PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.07 and traded as high as $0.12. PURE Bioscience shares last traded at $0.10, with a volume of 39,366 shares.
PURE Bioscience Stock Down 5.9 %
The stock has a market capitalization of $10.64 million, a P/E ratio of -2.38 and a beta of 0.05. The firm’s 50-day simple moving average is $0.08 and its 200 day simple moving average is $0.07.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Further Reading
- Five stocks we like better than PURE Bioscience
- What Are the U.K. Market Holidays? How to Invest and Trade
- Palantir Cracks $50, Is There Still Time to Get on Board?
- How to Invest in Insurance Companies: A Guide
- Insider Buying Signals Upside for These 3 Stocks
- Pros And Cons Of Monthly Dividend Stocks
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
